Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist neobomb1: Preclinical and first clinical results

Theranostic perspectives in prostate cancer with the gastrin-releasing peptide receptor antagonist neobomb1: Preclinical and first clinical results

BA Nock, A Kaloudi, E Lymperis, A Giarika… - Journal of Nuclear …, 2017 - Soc Nuclear Med

Abstract We recently introduced the potent gastrin-releasing peptide receptor (GRPR)
antagonist 68 Ga-SB3 (68 Ga-DOTA-p-aminomethylaniline-diglycolic acid-DPhe-Gln-Trp-
Ala-Val-Gly-His-Leu-NHEt), showing excellent tumor localizing efficacy in animal models 

For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:

*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.

*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.

*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.

*Peptide Salt: TFA, Desalt, Acetate, HCl.

*Peptide Purity: From crude to ＞99.5%.

*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.

*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Quick Links:

Peptide Price
Peptide Modification
Peptide Library
Quote Request
Contact Us

Contact Information:

Eva He
eva@pepmic.com

Pepmic Co., Ltd
www.pepmic.com